New hope for the 20 percent of kids who don't respond to standard cancer treatment
Oct 27, 2015
1 min read
A new drug combination being trialled in a groundbreaking CHU Sainte-Justine/University of Montreal study is giving hope for survival, healing and improved quality of life to the 20% of children who do not respond to standard cancer treatments.